Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
39.61
-0.30 (-0.75%)
Jul 7, 2025, 4:00 PM - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,294 employees as of December 31, 2024. The number of employees increased by 18 or 1.41% compared to the previous year.
Employees
1,294
Change (1Y)
18
Growth (1Y)
1.41%
Revenue / Employee
$456,483
Profits / Employee
-$424,713
Market Cap
3.74B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RARE News
- 10 days ago - Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome - GlobeNewsWire
- 17 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report - GlobeNewsWire
- 2 months ago - Ultragenyx to Participate at Bank of America's 2025 Healthcare Conference - GlobeNewsWire
- 2 months ago - Ultragenyx Pharmaceutical Inc. (RARE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 2 months ago - Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire